Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q4 2025 (December 31)5holders
0new positions
0sold out
$4.56avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were GAMMA Investing LLC ($225K), Fulton Bank, N.A. ($63K) and Rhumbline Advisers ($43K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 8,002 shares bought and 251 shares sold, net +7,751 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| GAMMA Investing LLC | 0.01% | Add +7.0% | 49,522 | $225K |
| Fulton Bank, N.A. | 0.00% | Reduce -1.8% | 13,604 | $63K |
| Rhumbline Advisers | 0.00% | Add +104.6% | 9,358 | $43K |
| Westside Investment Management, Inc. | 0.00% | No change | 3,747 | $17K |
| Salomon & Ludwin, LLC | 0.00% | No change | 31 | $143 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.